World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
102
Citations
36862
World Ranking
7688
National Ranking
752

Julian D. Gillmore publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Julian D. Gillmore sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 470 publications — 53rd percentile

53% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Julian D. Gillmore D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Julian D. Gillmore sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 102 D-Index — 63rd percentile

63% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Julian D. Gillmore is affiliated with University College London in the United Kingdom and has contributed extensively to research primarily in medicine and biochemistry, genetics, and molecular biology. Their work spans various topics with a focus on amyloidosis, its diagnosis, treatment, and outcomes.

Their recent publications include significant articles such as:

  • CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis (2021), published in New England Journal of Medicine
  • Efficacy and Safety of Acoramidis in Transthyretin Amyloid Cardiomyopathy (2024), published in New England Journal of Medicine

These papers reflect ongoing research into transthyretin amyloidosis and related therapeutic interventions.

Frequent coauthors in Gillmore's work include:

  • Philip N. Hawkins
  • Marianna Fontana
  • Helen J. Lachmann
  • Carol Whelan
  • Ana Martinez-Naharro

Publication venues where Gillmore's research regularly appears include:

  • Journal of the American College of Cardiology
  • Circulation
  • European Heart Journal
  • Amyloid
  • European Journal of Heart Failure

Gillmore's research fields highlight a multidisciplinary approach combining medicine with molecular biology, nephrology, genetics, rheumatology, and oncology. Subfields of particular emphasis are molecular biology, nephrology, and genetics.

Main topics covered in their research are broad, including:

  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • Parathyroid Disorders and Treatments
  • Eosinophilic Disorders and Syndromes
  • Peptidase Inhibition and Analysis
  • Medical Imaging and Pathology Studies
  • Neuroendocrine Tumor Research Advances
  • Protein Kinase Regulation and GTPase Signaling

Besides journal articles, Gillmore has contributed to academic books such as the 2023 publication "Proceedings and Predictions in Cardiac Amyloidosis: Unsolved mysteries and challenges for the future," published by Frontiers Media.

Best Publications

  • Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis.

    Julian D. Gillmore;Mathew S. Maurer;Rodney H. Falk;Giampaolo Merlini

  • CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis

    Julian D. Gillmore;Ed Gane;Jorg Taubel;Justin Kao

  • Natural history and outcome in systemic AA amyloidosis.

    Helen J Lachmann;Hugh J B Goodman;Janet A Gilbertson;J Ruth Gallimore

  • Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis.

    Helen J Lachmann;David R Booth;Susanne E Booth;Alison Bybee

  • Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases

    Pablo Garcia-Pavia;Claudio Rapezzi;Yehuda Adler;Michael Arad

  • Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein.

    Julian D Gillmore;Laurence B Lovat;Malcolm R Persey;Mark B Pepys

  • ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2—Evidence Base and Standardized Methods of Imaging

    Sharmila Dorbala;Yukio Ando;Sabahat Bokhari;Angela Dispenzieri

  • Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis

    Marianna Fontana;Silvia Pica;Patricia Reant;Amna Abdel-Gadir

  • A new staging system for cardiac transthyretin amyloidosis

    Julian D Gillmore;Thibaud Damy;Marianna Fontana;Matthew Hutchinson

  • Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy.

    Helen J. Lachmann;Ruth Gallimore;Julian D. Gillmore;Hugh D. Carr-Smith

  • A European collaborative study of treatment outcomes in 346 patients with cardiac stage III AL amyloidosis

    Ashutosh D. Wechalekar;Stefan O. Schonland;Efstathios Kastritis;Julian D. Gillmore

  • The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group.

    Nelson Leung;Frank Bridoux;Vecihi Batuman;Aristeidis Chaidos

  • Native T1 mapping in transthyretin amyloidosis

    Marianna Fontana;Sanjay M. Banypersad;Thomas A. Treibel;Viviana Maestrini

  • A European collaborative study of cyclophosphamide, bortezomib, and dexamethasone in upfront treatment of systemic AL amyloidosis.

    Giovanni Palladini;Sajitha Sachchithanantham;Paolo Milani;Julian Gillmore

  • Senile Systemic Amyloidosis: Clinical Features at Presentation and Outcome

    Jennifer H. Pinney;Carol J. Whelan;Aviva Petrie;Jason Dungu;Jason Dungu

  • T1 mapping and survival in systemic light-chain amyloidosis

    Sanjay M. Banypersad;Sanjay M. Banypersad;Marianna Fontana;Viviana Maestrini;Daniel M. Sado

  • Natural History, Quality of Life, and Outcome in Cardiac Transthyretin Amyloidosis.

    Thirusha Lane;Marianna Fontana;Ana Martinez-Naharro;Candida Cristina Quarta

  • Magnetic Resonance in Transthyretin Cardiac Amyloidosis.

    Ana Martinez-Naharro;Thomas A. Treibel;Amna Abdel-Gadir;Heerajnarain Bulluck

  • Antibodies to human serum amyloid P component eliminate visceral amyloid deposits

    Karl Bodin;Stephan Ellmerich;Melvyn C. Kahan;Glenys A. Tennent

  • Therapeutic Clearance of Amyloid by Antibodies to Serum Amyloid P Component

    Duncan B. Richards;Louise M. Cookson;Alienor C. Berges;Sharon V. Barton

Frequent Co-Authors

Helen J. Lachmann
Helen J. Lachmann University College London
James C. Moon
James C. Moon University College London
Philip N. Hawkins
Philip N. Hawkins University College London
Mark B. Pepys
Mark B. Pepys University College London
Giampaolo Merlini
Giampaolo Merlini University of Pavia
Vittorio Bellotti
Vittorio Bellotti University College London
Mathew S. Maurer
Mathew S. Maurer Columbia University
Rodney H. Falk
Rodney H. Falk Brigham and Women's Hospital
Efstathios Kastritis
Efstathios Kastritis National and Kapodistrian University of Athens

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Medicine but seeking alternative or complementary career paths, there are a variety of flexible online degree programs that can open doors in healthcare. Roles in healthcare administration, nutrition, and nursing leadership are just some of the many healthcare careers with strong demand across the USA.

An excellent starting point for leadership and management roles is a healthcare administration associate degree online. This program prepares students for entry-level administrative positions in hospitals, clinics, and other care facilities.

If you are already a registered nurse, adn to msn bridge programs online offer a fast track to advanced practice, teaching, or management roles within nursing. Similarly, a bachelor's in nutrition online can equip you to become a nutritionist, dietitian, or wellness consultant—crucial roles in preventative health and patient care.

For those aiming for higher-level administrative roles, a cahme accredited online mha (Master of Health Administration) degree is widely respected and geared toward future healthcare executives.

These online degrees offer the flexibility to study while working, and enable career advancement across various facets of the healthcare sector.

Best Scientists Citing Julian D. Gillmore

Trending Scientists

Recently Published Articles